Table 3.

Risk for all-cause mortality by insurance status and access to care for individuals with albuminuria

	All-cause mortality	P	CV mortality	P
N=	913		913
Unadjusted HR
No Insurance V Private (REF)	1.30(0.77,2.21)	0.316	1.30(0.50,3.40)	0.581
Public V Private	2.75(1.61,4.68)	<.001	2.30(1.12,4.72)	0.024
HR, Model 1a
No Insurance V Private (REF)	1.80(0.74,4.34)	0.189	1.96(0.66,5.77)	0.219
Public V Private	1.70(0.87,3.34)	0.118	1.73(0.63,4.76)	0.285
HR, Model 2b
No Insurance V Private (REF)	1.86(0.71,4.87)	0.199	1.88(0.46,7.58)	0.370
Public V Private	1.66(0.81,3.43)	0.165	1.48(0.47,4.65)	0.492
HR, Model 3c
No Insurance V Private (REF)	1.90(0.83,4.34)	0.125	1.95(0.56,6.85)	0.288
Public V Private	1.87(1.01,3.46)	0.046	1.57(0.52,4.73)	0.417
HR, Model 4d
No Insurance V Private (REF)	2.97(1.29,6.85)	0.012	2.15(0.44,10.46)	0.337
Public V Private	3.65(1.74,7.67)	<.001	3.21(0.77,13.43)	0.107

^aModel 1: Sociodemographic: age, gender, race/ethnicity, PIR (poverty income ratio), education, marital status

^bModel 2: Model 1+ Diabetes (Y/N), Cardiovascular disease (Y/N), smoking (Y/N), Body mass index, cancer (y/n)

^cModel 3: Model 2+ estimated glomerular filtration rate (eGFR), systolic blood pressure, cholesterol (<200 mg/dL, >200 mg/dL HgbA1c (<7, >7)

^dModel 4: Model 3 + statin(Y/N), angiotension converting enzyme (ACE)-Inhibitor (yes/no)